Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128010312> ?p ?o ?g. }
- W3128010312 endingPage "108467" @default.
- W3128010312 startingPage "108467" @default.
- W3128010312 abstract "Huntington's disease (HD) is due to a mutation in the gene encoding for Huntingtin protein generating polyQ domain extension. Mutant Htt (mHtt) leads to important dysfunction of the BDNF/TrkB signaling. We previously described the 23aa Htt fragment P42, that attenuated the pathological phenotypes induced by mHtt. We reported that, in the R6/2 mouse model of HD, P42 rescued striatal TrkB level but marginally increased cortical BDNF. In the present study, our aim was to address P42 neuroprotection in presence of an external input of BDNF. We combined P42 administration with environmental enrichment (EE), induced by training in the Hamlet test. We examined the consequences of P42 + EE combination on different phenotypes in R6/2 HD mice: motor and cognitive performances, recorded at early and late pathological stages, and analyzed aggregated mHtt and BDNF levels in forebrain structures. Hamlet exploration (i.e., entries in Run, Hide, Eat, Drink and Interact houses) was gradually impaired in R6/2 mice, but maintained by P42 treatment until week 8. Topographic memory alteration measured at week 7 was attenuated by P42. Motor performances (rotarod) were significantly ameliorated by the P42 + EE combination until late stage (week 12). The P42 + EE combination also significantly decreased aggregated Htt levels in the hippocampus, striatum and cortex, and increased BDNF levels in the cortex and striatum. We concluded that combination between P42 treatment, known to increase TrkB striatal expression, and a BDNF-enhancing therapy such as EE efficiently delayed HD pathology in R6/2 mice. Use of dual therapies might be a pertinent strategy to fight neurodegeneration in HD." @default.
- W3128010312 created "2021-02-15" @default.
- W3128010312 creator A5045510832 @default.
- W3128010312 creator A5054642476 @default.
- W3128010312 creator A5055921478 @default.
- W3128010312 creator A5065055379 @default.
- W3128010312 creator A5076052974 @default.
- W3128010312 creator A5078398415 @default.
- W3128010312 date "2021-03-01" @default.
- W3128010312 modified "2023-09-26" @default.
- W3128010312 title "Exposure of R6/2 mice in an enriched environment augments P42 therapy efficacy on Huntington's disease progression" @default.
- W3128010312 cites W1488872763 @default.
- W3128010312 cites W1496088120 @default.
- W3128010312 cites W1593555249 @default.
- W3128010312 cites W1639255528 @default.
- W3128010312 cites W1652798871 @default.
- W3128010312 cites W1972251644 @default.
- W3128010312 cites W1984200333 @default.
- W3128010312 cites W1991506806 @default.
- W3128010312 cites W1995051993 @default.
- W3128010312 cites W2014377303 @default.
- W3128010312 cites W2018254952 @default.
- W3128010312 cites W2026124745 @default.
- W3128010312 cites W2027835288 @default.
- W3128010312 cites W2028865828 @default.
- W3128010312 cites W2030776582 @default.
- W3128010312 cites W2040409885 @default.
- W3128010312 cites W2041433408 @default.
- W3128010312 cites W2044715983 @default.
- W3128010312 cites W2047636024 @default.
- W3128010312 cites W2056798963 @default.
- W3128010312 cites W2056920798 @default.
- W3128010312 cites W2058039595 @default.
- W3128010312 cites W2062867276 @default.
- W3128010312 cites W2067046755 @default.
- W3128010312 cites W2071776514 @default.
- W3128010312 cites W2077305976 @default.
- W3128010312 cites W2081254560 @default.
- W3128010312 cites W2085838487 @default.
- W3128010312 cites W2095099413 @default.
- W3128010312 cites W2107522917 @default.
- W3128010312 cites W2110715131 @default.
- W3128010312 cites W2125224248 @default.
- W3128010312 cites W2129630363 @default.
- W3128010312 cites W2131091928 @default.
- W3128010312 cites W2140572389 @default.
- W3128010312 cites W2146267270 @default.
- W3128010312 cites W2167725117 @default.
- W3128010312 cites W2255469197 @default.
- W3128010312 cites W2302010976 @default.
- W3128010312 cites W2314644980 @default.
- W3128010312 cites W2326356380 @default.
- W3128010312 cites W2756440182 @default.
- W3128010312 cites W2792739742 @default.
- W3128010312 cites W2804116953 @default.
- W3128010312 cites W2806774178 @default.
- W3128010312 cites W2946190357 @default.
- W3128010312 cites W2997197203 @default.
- W3128010312 cites W3082474640 @default.
- W3128010312 cites W4211110682 @default.
- W3128010312 cites W602042395 @default.
- W3128010312 doi "https://doi.org/10.1016/j.neuropharm.2021.108467" @default.
- W3128010312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33516737" @default.
- W3128010312 hasPublicationYear "2021" @default.
- W3128010312 type Work @default.
- W3128010312 sameAs 3128010312 @default.
- W3128010312 citedByCount "9" @default.
- W3128010312 countsByYear W31280103122021 @default.
- W3128010312 countsByYear W31280103122022 @default.
- W3128010312 countsByYear W31280103122023 @default.
- W3128010312 crossrefType "journal-article" @default.
- W3128010312 hasAuthorship W3128010312A5045510832 @default.
- W3128010312 hasAuthorship W3128010312A5054642476 @default.
- W3128010312 hasAuthorship W3128010312A5055921478 @default.
- W3128010312 hasAuthorship W3128010312A5065055379 @default.
- W3128010312 hasAuthorship W3128010312A5076052974 @default.
- W3128010312 hasAuthorship W3128010312A5078398415 @default.
- W3128010312 hasBestOaLocation W31280103121 @default.
- W3128010312 hasConcept C126322002 @default.
- W3128010312 hasConcept C134018914 @default.
- W3128010312 hasConcept C15744967 @default.
- W3128010312 hasConcept C160539049 @default.
- W3128010312 hasConcept C169760540 @default.
- W3128010312 hasConcept C170493617 @default.
- W3128010312 hasConcept C25498285 @default.
- W3128010312 hasConcept C2779134260 @default.
- W3128010312 hasConcept C2779715522 @default.
- W3128010312 hasConcept C2780062018 @default.
- W3128010312 hasConcept C2780647506 @default.
- W3128010312 hasConcept C2781161787 @default.
- W3128010312 hasConcept C2781427258 @default.
- W3128010312 hasConcept C513476851 @default.
- W3128010312 hasConcept C529278444 @default.
- W3128010312 hasConcept C71924100 @default.
- W3128010312 hasConcept C97124661 @default.
- W3128010312 hasConceptScore W3128010312C126322002 @default.
- W3128010312 hasConceptScore W3128010312C134018914 @default.
- W3128010312 hasConceptScore W3128010312C15744967 @default.